FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
25 letters match. Newest first.
-
DrugsFareva Amboise
FDA warned Fareva Amboise in France about sterile drug manufacturing failures, including aseptic practice and data integrity problems.
High risk -
DrugsExcelvision - Fareva
FDA warned Excelvision-Fareva after a 2026 inspection found inadequate contamination investigations and aseptic failures for sterile drugs.
High risk -
DrugsFagron BV
FDA warns Fagron's Canton, MA sterile compounding site over airflow, cleaning and investigation failures, prompting a recall.
High risk -
DrugsMedline Inc
FDA warned Medline Inc about repeated Bacillus cereus contamination in its drug products and inadequate investigations.
High risk -
DrugsProRx LLC
ProRx LLC, an outsourcing facility, made sterile compounded drugs under insanitary conditions and without required 503B eligibility.
High risk -
DrugsSimtra BioPharma Solutions
FDA found contamination risks in Simtra's sterile drug manufacturing in Germany, including microbial recoveries, failed isolator tests, and inadequate decontamination.
High risk -
FoodJohn Yoder Farm
FDA warns John Yoder Farm over shell eggs and missing Salmonella prevention plan.
High risk -
FoodNorth Creek Farm
FDA warns North Creek Farm that its shell eggs are unsafe under food law because it lacked Salmonella Enteritidis controls.
High risk -
DevicesUscom Kft
Uscom Kft marketed SpiroSonic AIR spirometer in the U.S. without FDA clearance and had multiple quality system failures at its Budapest plant.
High risk -
DrugsDaewoo Pharmaceutical Co., Ltd.
FDA warns Daewoo Pharmaceutical over CGMP (manufacturing quality rules) failures at Busan plant; company suspended production.
High risk -
FoodVoehlganic Farm LLC
FDA warned Voehlganic Farm LLC that its shell eggs are adulterated because it lacked a Salmonella Enteritidis prevention plan and testing.
High risk -
DrugsExcelvision Fareva
Excelvision Fareva, a sterile drug manufacturer, was cited for inadequate mold/black-speck complaint investigations and aseptic contamination controls.
High risk -
DrugsStrukmyer LLC dba Strukmyer Medical
Strukmyer Medical was cited for current good manufacturing practice violations after FDA found repeated microbial contamination in water used to make OTC drugs.
High risk -
BiologicsBioStem Life Sciences
FDA says BioStem Life Sciences made unapproved umbilical cord and amniotic products with significant CGMP violations.
High risk -
FoodLoyd Sanabria Hernandez dba Avicola Santa Fe
FDA warns Puerto Rico shell egg farm Avicola Santa Fe over Salmonella prevention, testing, and registration failures.
High risk -
DrugsRegenerative Processing Plant, LLC
FDA warns Regenerative Processing Plant over unapproved, misbranded Regener-Eyes eye drops and serious sterile manufacturing violations.
High risk -
BiologicsNeobiosis, LLC
FDA warns Neobiosis over unapproved amniotic fluid and umbilical cord products and serious manufacturing quality failures.
High risk -
DrugsMadhu Instruments Private Limited
FDA cites Madhu Instruments in New Delhi for insanitary conditions in sterile drug manufacturing and places it on import alert.
High risk -
FoodIowa Egg Company Inc.
Iowa Egg Company Inc. shell egg farm cited for Salmonella Enteritidis prevention, temperature, pest, testing and record violations.
High risk -
BiologicsKimera Labs, Inc.
FDA warns Kimera Labs over unapproved exosome and amniotic fluid products and serious sterile manufacturing failures.
High risk -
FoodLathem Family Farms, Inc.
Lathem Family Farms' shell eggs are adulterated; FDA found a resident Salmonella Enteritidis strain and shell egg rule violations.
High risk -
BiologicsSignature Biologics, LLC
FDA cited Signature Biologics for unapproved, unlicensed Signature Cord and serious sterile manufacturing failures.
High risk -
BiologicsStratus Biosystems, LLC dba CellGenuity Regenerative Science
FDA warns CellGenuity over unapproved amniotic/umbilical products and serious sterility failures.
High risk -
BiologicsRe-Gen Active Lab, Inc.
FDA warned Re-Gen Active Lab over unapproved amniotic/umbilical cord injectables and serious sterility failures.
High risk -
DrugsBrigham and Women’s Hospital Inc.
Brigham and Women’s Hospital PET drug facility had water leaks and fungal contamination in aseptic areas, FDA says.
High risk